Anti-inflammation-based treatment of atherosclerosis using Gliclazide-loaded biomimetic nanoghosts
Crossref DOI link: https://doi.org/10.1038/s41598-023-41136-y
Published Online: 2023-08-24
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Karami, Zahra
Mehrzad, Jalil
Akrami, Mohammad
Hosseinkhani, Saman
Text and Data Mining valid from 2023-08-24
Version of Record valid from 2023-08-24
Article History
Received: 26 September 2022
Accepted: 22 August 2023
First Online: 24 August 2023
Competing interests
: The authors declare no competing interests.